Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:13 pm Purchase |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 8,872,000 9.990% |
1,514,000 (+20.58%) |
Filing History |
| 2025-05-15 10:47 am Sale |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 2,921,196 3.300% |
-2,052,453 (-41.27%) |
Filing History |
| 2025-05-15 06:18 am Purchase |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
Macquarie Group Limited | 4,797,314 5.410% |
537,757 (+12.62%) |
Filing History |
| 2025-05-14 11:48 am Purchase |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
JANUS HENDERSON GROUP PLC JHG |
7,566,963 8.500% |
7,534,783 (+23414.49%) |
Filing History |
| 2025-04-30 11:22 am Sale |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 5,014,020 5.650% |
-1,728,145 (-25.63%) |
Filing History |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
6,689,435 7.500% |
-1,328,857 (-16.57%) |
Filing History |
| 2025-02-14 5:22 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 7,358,000 9.620% |
-290,000 (-3.79%) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 2,114,056 2.400% |
-2,226,284 (-51.29%) |
Filing History |
| 2025-02-14 09:10 am Purchase |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,973,649 5.720% |
561,666 (+12.73%) |
Filing History |
| 2025-02-07 07:44 am Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Macquarie Group Limited | 4,259,557 4.900% |
-486,587 (-10.25%) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
BlackRock Inc. BLK |
8,018,292 9.400% |
28,272 (+0.35%) |
Filing History |
| 2025-01-31 10:09 am Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 6,742,165 7.750% |
-159,985 (-2.32%) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 7,648,000 10.000% |
264,000 (+3.58%) |
Filing History |
| 2024-11-14 1:01 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 4,340,340 5.700% |
4,340,340 (New Position) |
Filing History |
| 2024-11-14 09:46 am Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 531,857 0.700% |
-6,990,424 (-92.93%) |
Filing History |
| 2024-11-12 5:56 pm Unchanged |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 6,902,150 9.020% |
0 (Unchanged) |
Filing History |
| 2024-11-08 4:55 pm Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
MORGAN STANLEY MS |
1,319,809 1.700% |
-2,832,637 (-68.22%) |
Filing History |
| 2024-11-04 1:55 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
The Vanguard Group | 6,902,150 9.020% |
1,387,007 (+25.15%) |
Filing History |
| 2024-10-18 11:59 am Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
STATE STREET CORP STT |
2,736,696 3.600% |
-2,615,649 (-48.87%) |
Filing History |
| 2024-05-01 4:11 pm Purchase |
2024-04-25 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,411,983 5.790% |
4,411,983 (New Position) |
Filing History |